FOXO1 Gene Rearrangements
FKHR-PAX3 or FKHR-PAX7
Notes
**Note 1:** This SSDI is effective for diagnosis years 2023+. * For cases diagnosed 2018-2022, leave this SSDI blank **Note 2:** Physician statement of FOXO1 gene rearrangements can be used to code this data item. **Note 3:** If the presence/absence of FOXO1 gene rearrangements determined by available test results differs from the physician statement of presence/absence, the physician’s statement takes precedence. **Note 4:** This test is almost always done for Alveolar Rhabdomyosarcomas. Embryonal Rhabdomyosarcomas are usually negative, and therefore the test is usually not done.NAACCR Item
NAACCR #9609Metadata
SSDI| Code | Description |
|---|---|
| 0 | No gene rearrangements (fusions) identified |
| 1 | FOXO1-PAX3 gene rearrangement (fusion) present |
| 2 | FOXO1-PAX7 gene rearrangement (fusion) present |
| 3 | FOXO1-PAX3 and FOXO1-PAX7 gene rearrangements (fusions) present |
| 4 | FOXO1 gene rearrangement present, fusion partner not known |
| 7 | Test ordered, results not in chart |
| 8 | Not applicable: Information not collected for this case (If this information is required by your standard setter, use of code 8 may result in an edit error.) |
| 9 | Not documented in medical record Cannot be determined by pathologist FOXO1 gene rearrangement not assessed or unknown if assessed |
| <BLANK> | N/A - Diagnosis year is prior to 2023 |